Riskpilot← Back to searchSign inGet full accessHospitad AB
ABActiveOrg 5592252844Rostocksvägen 10Business and other management consultancy activities · NACE 7020Est. 20190 employees
Revenue 2024
SEK 1,9M
EBITDA margin
200.1%
+194% vs 2023
Equity ratio
96.7%
Financial strength
Net profit 2024
SEK 3,6M
+202% vs 2023
| Revenue | SEK 1,9M | — |
| EBITDA | SEK 3,7M | +194% |
| Net profit | SEK 3,6M | +202% |
| Total assets | SEK 11,7M | +29% |
| Equity | SEK 11,4M | +47% |
| Employees | 0 | — |
Legal name
Hospitad AB
Org number
5592252844
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
5 november 2019
Share capital
SEK 74 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall äga och förvalta fast och lös egendom samt bedriva därmed förenlig verksamhet.
Address
Rostocksvägen 10
Email
leo1209@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 209 | 197 | 148 | 0 | 1 854 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −36 | −2 829 | −8 579 | −3 955 | 3 710 |
| Depreciation & amort. | −2 | −5 | −5 | −13 | −17 |
| EBIT | −38 | −2 834 | −8 584 | −3 968 | 3 693 |
| Net financials | −2 | 20 | −864 | 419 | −68 |
| Profit before tax | −41 | −2 814 | −9 016 | −3 550 | 3 625 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −41 | −2 814 | −9 016 | −3 550 | 3 625 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 231 | 655 | 12 252 | 9 084 | 11 739 |
| Equity | 159 | 346 | 11 281 | 7 731 | 11 356 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 72 | 309 | 971 | 1 354 | 383 |
| Total debt | 72 | 309 | 971 | 1 354 | 383 |
EBITDA margin
200.1%
This company
15.8%
Market median
+1166% vs market
20202024
Equity ratio
96.7%
This company
38.2%
Market median
+153% vs market
20202024
Return on equity
31.9%
This company
18.4%
Market median
+73% vs market
20202024
Net profit margin
195.5%
This company
8.1%
Market median
+2314% vs market
20202024
Asset turnover
0.16×
This company
1.12×
Market median
-86% vs market
20202024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-11-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TM Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2024 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Chairman | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Hospitad AB (this company)
Parslylabs Unipessoal LdaPARSLYLABS UNIPESSOAL LDABoard members of Hospitad AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tony Mikael Salonen | Chief Auditor | 0 companies |
| Ramzi Ferchichi | Board of Directors | 0 companies |
| Ilie Komo | Board of Directors | 0 companies |
| Björn Oscar Alexander von Sivers | Board of Directors | 0 companies |
| Piroz Hasanizadeh Bina | Deputy Board Member | 0 companies |
| Meybod Kia | Deputy Board Member | 0 companies |
| Leonard Milad Kia | Chairman | 0 companies |